NTRA insider trading — Natera, Inc.
No open-market insider purchases or sales were filed for Natera, Inc. (NTRA) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent NTRA insider transactions
Every Form 4 filed by Natera, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | G · Gift | Direct | 6,000 | — | — | Form 4 |
| Oct 1, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | S · Sale · 10b5-1 | Direct | 1,273 | $413.31 | $526K | Form 4 |
| Oct 1, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S · Sale · 10b5-1 | Direct | 3,000 | $414.22 | $1.24M | Form 4 |
| Sep 23, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Indirect | 18,064 | $388.01 | $7.01M | Form 4 |
| Sep 16, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G · Gift | Direct | 945 | — | — | Form 4 |
| Sep 16, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 3,150 | $354.19 | $1.12M | Form 4 |
| Sep 15, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 6,000 | $350.07 | $2.10M | Form 4 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Direct | 50,000 | $347.19 | $17.36M | Form 4 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Indirect | 2,000 | $350.01 | $700K | Form 4 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Direct | 50,000 | $334.76 | $16.74M | Form 4 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Direct | 50,000 | $327.97 | $16.40M | Form 4 |
| Sep 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S · Sale · 10b5-1 | Direct | 15,160 | $326.89 | $4.96M | Form 4 |
| Sep 1, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S · Sale · 10b5-1 | Direct | 3,000 | $320.73 | $962K | Form 4 |
| Sep 1, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | S · Sale · 10b5-1 | Direct | 1,698 | $320.99 | $545K | Form 4 |
| Aug 10, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | S · Sale · 10b5-1 | Direct | 6,517 | $321.53 | $2.10M | Form 4 |
| Aug 6, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | A · Grant/award · 10b5-1 | Direct | 20,000 | — | — | Form 4 |
| Aug 10, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 6,000 | $325.32 | $1.95M | Form 4 |
| Aug 7, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Indirect | 2,000 | $320.90 | $642K | Form 4 |
| Aug 7, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 9,150 | $315.66 | $2.89M | Form 4 |
| Aug 4, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S · Sale · 10b5-1 | Direct | 478 | $274.22 | $131K | Form 4 |
| Aug 3, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S · Sale · 10b5-1 | Direct | 317 | $267.99 | $85K | Form 4 |
| Aug 3, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | S · Sale · 10b5-1 | Direct | 334 | $267.99 | $90K | Form 4 |
| Aug 3, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 109 | $267.99 | $29K | Form 4 |
| Aug 3, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S · Sale · 10b5-1 | Direct | 3,410 | $265.58 | $906K | Form 4 |
| Aug 3, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | S · Sale · 10b5-1 | Direct | 3,076 | $266.39 | $819K | Form 4 |
| Aug 3, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | S · Sale · 10b5-1 | Direct | 295 | $267.99 | $79K | Form 4 |
| Aug 3, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Direct | 731 | $267.99 | $196K | Form 4 |
| Jul 29, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S · Sale · 10b5-1 | Direct | 1,863 | $249.38 | $465K | Form 4 |
| Jul 28, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S · Sale · 10b5-1 | Direct | 2,419 | $253.96 | $614K | Form 4 |
| Jul 28, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | S · Sale · 10b5-1 | Direct | 1,003 | $254.07 | $255K | Form 4 |
| Jul 28, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 191 | $254.07 | $49K | Form 4 |
| Jul 28, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | S · Sale · 10b5-1 | Direct | 3,580 | $254.07 | $910K | Form 4 |
| Jul 28, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | S · Sale · 10b5-1 | Direct | 931 | $254.07 | $237K | Form 4 |
| Jul 28, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S · Sale · 10b5-1 | Direct | 1,204 | $254.07 | $306K | Form 4 |
| Jul 27, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | S · Sale · 10b5-1 | Direct | 1,718 | $260.49 | $448K | Form 4 |
| Jul 27, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | S · Sale · 10b5-1 | Direct | 782 | $260.49 | $204K | Form 4 |
| Jul 27, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | S · Sale · 10b5-1 | Direct | 884 | $260.49 | $230K | Form 4 |
| Jul 27, 2026 | Sheena Jonathan | Director | S · Sale · 10b5-1 | Direct | 288 | $260.49 | $75K | Form 4 |
| Jul 27, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | S · Sale · 10b5-1 | Direct | 2,190 | $260.49 | $570K | Form 4 |
| Jul 27, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | S · Sale · 10b5-1 | Direct | 782 | $260.49 | $204K | Form 4 |
| Jul 27, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S · Sale · 10b5-1 | Direct | 1,010 | $260.49 | $263K | Form 4 |
NTRA insider trading FAQ
Are insiders buying NTRA stock?
Not on the open market. In the last 90 days, Natera, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading NTRA?
No insider bought or sold on the open market in the last 90 days.
Where does NTRA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.